SomaLogic is using its unique proteomics technology – the SOMAscan® assay – to help identify new biomarkers for a wide range of disease states. Capable of simultaneously measuring thousands of proteins in low volume biological samples, this technique is ideal for the detection of low abundance proteins, perfectly complementing existing technologies for basic science, biomarker discovery and pharmaceutical research.
Thermo Fisher Scientific is helping to drive biotherapeutic research with the development of innovative sample processing tools designed to simplify and accelerate analytical workflows. Offering automation-friendly affinity purification for proteins and antibodies, this provides a robust solution for high throughput preclinical research and development.
Freiburg-based Oncotest GmbH specializes in preclinical pharmacological contract research, and has successfully automated 3D cell culture on a Freedom EVO® workstation using polystyrene-based Alvetex® Scaffold 96-well plates from Reinnervate.